News

News

Public Comments Reveal Widespread Unity in Opposition to NIST’s March-In Rights Framework

News

WTO appears close to rejecting a proposed waiver on patents for Covid diagnostics and therapies

News

KFF Health News: Morning Briefing

News

Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better

News

The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows

News

Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say

News

Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing

News

AI adds urgency to patent debate

News

Special council works to protect and promote STEM excellence

News

#27 Jamie Simpson | The U.S. policy perspective on SEPs

Scroll to Top